Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 493

1.

Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.

Prasad K, Karlupia N.

Respir Med. 2007 Oct;101(10):2037-43. Epub 2007 Aug 13. Review.

2.

Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.

Patel M, Lee CK.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001093. Review.

PMID:
15674874
3.

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Noronha CP, Struchiner CJ, Halloran ME.

Int J Epidemiol. 1995 Oct;24(5):1050-7.

PMID:
8557439
4.

Meningococcal conjugate vaccines.

Zimmer SM, Stephens DS.

Expert Opin Pharmacother. 2004 Apr;5(4):855-63. Review.

PMID:
15102568
5.

Serogroup B meningococcal vaccines.

Zimmer SM, Stephens DS.

Curr Opin Investig Drugs. 2006 Aug;7(8):733-9. Review.

PMID:
16955685
6.

Vaccines for the prevention of meningococcal disease in children.

Soriano-Gabarró M, Stuart JM, Rosenstein NE.

Semin Pediatr Infect Dis. 2002 Jul;13(3):182-9. Review.

PMID:
12199614
7.

Bacterial meningitis: the impact of vaccination.

Makwana N, Riordan FA.

CNS Drugs. 2007;21(5):355-66. Review.

PMID:
17447825
8.

Treatment of bacterial meningitis: an overview of Cochrane systematic reviews.

Prasad K, Karlupia N, Kumar A.

Respir Med. 2009 Jul;103(7):945-50. doi: 10.1016/j.rmed.2009.03.019. Epub 2009 Apr 17. Review.

9.

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.

Int J Infect Dis. 2008 May;12(3):278-88. Epub 2007 Nov 5.

10.

Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.

Campagne G, Schuchat A, Djibo S, Ousséini A, Cissé L, Chippaux JP.

Bull World Health Organ. 1999;77(6):499-508.

11.

Expanding prevention of invasive meningococcal disease.

Pelton SI, Gilmet GP.

Expert Rev Vaccines. 2009 Jun;8(6):717-27. doi: 10.1586/erv.09.37. Review.

PMID:
19485753
12.

Towards an improved serogroup B Neisseria meningitidis vaccine.

Perrett KP, Pollard AJ.

Expert Opin Biol Ther. 2005 Dec;5(12):1611-25. Review.

PMID:
16318425
13.

Meningococcal conjugate vaccines: efficacy and new combinations.

Sáfadi MA, Barros AP.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S35-44. Review.

14.

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

Okoko BJ, Idoko OT, Adegbola RA.

Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16. Review.

PMID:
19095025
15.

Quadrivalent meningococcal conjugate vaccines.

Pace D, Pollard AJ, Messonier NE.

Vaccine. 2009 Jun 24;27 Suppl 2:B30-41. doi: 10.1016/j.vaccine.2009.05.003. Epub 2009 May 27. Review.

PMID:
19477560
16.

Neisseria meningitidis serogroup A vaccines: an overview.

Vergnano S, Heath P.

Expert Rev Vaccines. 2003 Aug;2(4):571-82. Review.

PMID:
14711341
17.

Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.

Soriano-Gabarró M, Rosenstein N, LaForce FM.

J Health Popul Nutr. 2004 Sep;22(3):275-85.

PMID:
15609780
18.

[Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].

Magdzik W.

Przegl Epidemiol. 2004;58(2):241-51. Polish.

PMID:
15521103
19.

Prevention of meningococcal disease.

Woodard JL, Berman DM.

Fetal Pediatr Pathol. 2006 Nov-Dec;25(6):311-9. Review.

PMID:
17696042
20.

WITHDRAWN: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.

Conterno LO, da Silva Filho CR, Ruggeberg JU, Heath PT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD001834. doi: 10.1002/14651858.CD001834.pub3. Review.

PMID:
21735387
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk